quinoxalines has been researched along with Long Sleeper Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berg, A; Foulds, J; Franzon, M; Galaznik, A; Hughes, JR; Russ, C; Yu, CR; Zou, KH | 1 |
Cieślewicz, A; Jabłecka, A; Korzeniowska, K | 1 |
Caduff-Janosa, P; Savage, RL; Zekarias, A | 1 |
Gunnell, D; Higgins, JP; Knipe, DW; Martin, RM; Thomas, KH | 1 |
Harrison-Woolrych, M | 1 |
Cahill, K; Lancaster, T | 1 |
Davies, S; Flammer, M; Hughes, J; Russ, C; Tonstad, S | 1 |
Ashton, J; Harrison-Woolrych, M | 1 |
2 review(s) available for quinoxalines and Long Sleeper Syndrome
Article | Year |
---|---|
Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis.
Topics: Aggression; Benzazepines; Depression; Humans; Mental Disorders; Quinoxalines; Risk Factors; Sleep Wake Disorders; Suicide; Suicide, Attempted; Tobacco Use Cessation Devices; Varenicline | 2015 |
Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
Topics: Adolescent; Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Incidence; Male; Mental Disorders; Middle Aged; Nicotinic Agonists; Placebos; Quinoxalines; Randomized Controlled Trials as Topic; Risk; Sleep Wake Disorders; Smoking Cessation; Varenicline | 2010 |
1 trial(s) available for quinoxalines and Long Sleeper Syndrome
Article | Year |
---|---|
Effect of varenicline on individual nicotine withdrawal symptoms: a combined analysis of eight randomized, placebo-controlled trials.
Topics: Adult; Aged; Benzazepines; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Varenicline | 2013 |
5 other study(ies) available for quinoxalines and Long Sleeper Syndrome
Article | Year |
---|---|
[Safety of nicotine addiction treatment].
Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Quinolizines; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Tobacco Use Disorder; Varenicline; Xerostomia | 2013 |
Varenicline and abnormal sleep related events.
Topics: Adult; Aggression; Benzazepines; Dreams; Drug Labeling; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Parasomnias; Pharmacovigilance; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Somnambulism; Varenicline; World Health Organization | 2015 |
Mental health effects of varenicline.
Topics: Benzazepines; Humans; Mental Disorders; Quinoxalines; Sleep Wake Disorders; Tobacco Use Cessation Devices; Varenicline | 2015 |
ACP Journal Club. Review: Varenicline does not differ from placebo for adverse neuropsychiatric events.
Topics: Benzazepines; Humans; Mental Disorders; Quinoxalines; Sleep Wake Disorders; Tobacco Use Cessation Devices | 2015 |
Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand.
Topics: Adult; Aged; Aged, 80 and over; Benzazepines; Cohort Studies; Female; Follow-Up Studies; Humans; Male; Mental Disorders; Middle Aged; New Zealand; Nicotinic Agonists; Product Surveillance, Postmarketing; Prospective Studies; Quinoxalines; Sleep Wake Disorders; Smoking Cessation; Surveys and Questionnaires; Varenicline; Young Adult | 2011 |